DOCUMENT RESOURCES FOR EVERYONE
Documents tagged
Business InSite Vision Corporate Presentation

1. Corporate Presentation: Annual Shareholder Meeting Tim Ruane, CEO InSite Vision May 31, 2012 2. Our Approach:  Novel Products, Reduced Risk, Efficient Development…

Documents Sat 0715 Breakfast Symposium Donnenfeld Blepharitis

Pathophysiology, Diagnosis and Treatment of Blepharitis and Meibomian Gland Dysfunction Eric Donnenfeld, MD Clinical Professor of Ophthalmology NYU Trustee Dartmouth Medical…

Documents Common Blepharitis Related to Phthiriasis Palpebrarum: Argon Laser Phototherapy

ABSTRACT A 42-year-old woman was admitted to Mersin University, Department of Ophthalmology Clinic with itching and burning sensation of the right eye for 3 weeks. In her

Documents A Rare Case of Blebharitis: Phthiriasis Palpebrarum

Address for Correspondence / Yazma Adresi: Oktay Alver E.mail: [email protected] DOI: 10.5152/tpd.2018.4824 ©Copyright 2018 Turkish Society for Parasitology -

Documents Eyelid Infestation: A Case Report of Atypical Phthiriasis Palpebrarum

Review began 05/18/2022 Review ended 05/24/2022 Published 05/27/2022 © Copyright 2022 Correia Barbosa et al. This is an open access article distributed under the terms

Documents A Case of an Exceptional and Infrequent Reason of Blepharoconjunctivitis : Phthiriasis Palpebrarum

STSNA VE NADR BR SEBEBE BALI BR BLEFAROKONJONKTVT OLGUSU: PTRYASS PALPEBRARUM A Case of an Exceptional and Infrequent Reason of Blepharoconjunctivitis : Phthiriasis Palpebrarum

Documents Chronic Eyelid Lymphedema and Acne Rosacea

PII: S0161-6420(00)00429-2Chronic Eyelid Lymphedema and Acne Rosacea Report of Two Cases Francesco P. Bernardini, MD,1 Robert C. Kersten, MD,2 Lucie M. Khouri, MD,2 Muhammad

Documents Oxytetracycline in the treatment of ocular rosacea: a double-blind trial

British Journal of Ophthalmology, 1982, 66, 386-388 Oxytetracycline in the treatment of ocular rosacea: a double-blind trial R. S. BARTHOLOMEW,' B. J. REID,2 M. J. CHEESBROUGH,3

Documents Blepharitis

This information can be made available in alternative formats, such as easy read or large print on request. Please call PALS: 020 7566 2324/ 020 7566 2325 1 Patient information